Skip to main content

Table 9 TB incidence in month interval among IPT completed, in-completed & non-exposed patients in public health facilities of Addis Ababa, during 2007-June 2012

From: Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study

Follow up month

IPT exposure/completion status

IR/100 P-M (95% CI)

Unadjusted IRR (95% CI)

Adjusted IRR (95% CI)

<6

Completed

0

0

0

In-complete

142.8(17.64–268.07)

1.82(0.65–3.97)

2.125(0.712–5.103)

Non-exposed

78.59(66.9–90.3)

1

1

6–12

Completed

12(1.58–25.58)

0.30(0.06–0.79)

0.03(0.013–1.95)

In-completed

38.71(7.74–69.68)

0.98(0.39–2.02)

1.05(0.32–2.89)

Non-exposed

39.43(34.05–44.82)

1

1

12–24

Completed

6.74(1.35–12.14)

0.29(0.11–0.59)

0.03(0.01–0.74)

In-completed

38.71(7.74–69.68)

1.65(0.65–3.38)

1.61(0.51–4.29)

Non-exposed

23.51(20.48–26.55)

1

1

24–36

Completed

5.98(1.55–10.42)

0.34(0.14–0.66)

0.04(0.02–1.74)

In-completed

9.94(3.05–16.82)

0.56(0.25–1.05)

1.09(0.49–2.54)

Non-exposed

17.87(15.63–20.11)

1

1

37–48

Completed

5.98(1.55–10.42)

0.44(0.186–0.854)

0.74(0.301–1.56)

In-completed

9.94(3.05–16.82)

0.73(0.33–1.37)

0.72(0.314–1.44)

Non-exposed

13.72(12.04–19.56

1

1

>48

Completed

5.98(1.55–10.42)

0.50(0.22–0.99)

0.88(0.36–1.84)

In-completed

9.94(3.05–16.82)

0.84(0.38–1.58)

0.89(0.39–1.76)

Non-exposed

11.88(10.44–13.32)

1

1